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There are not enough nationwide studies on perinatal HIV transmission in connection with a
combination of antiretroviral treatments in Spain. Our objectives were to study sociodemo-
graphic changes and trends in the rates of HIV diagnoses and perinatal transmission in
Spain from 1997 to 2015.
Methods
A retrospective study using data from Spanish Paediatric HIV Network (CoRISpe) and
Spanish Minimum Basic Data Set (MDBS) was performed. HIV- diagnosed children
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between 1997 and 2015 were selected. Sociodemographic, clinical and immunovirological
data of HIV-infected children and their mothers were studied in four calendar periods (P1:
1997–2000; P2: 2001–2005; P3: 2006–2010; P4: 2011–2015). Rates of perinatal HIV diag-
noses and transmission from 1997 to 2015 were calculated.
Results
A total of 532 HIV-infected children were included in this study. Of these children, 406 were
Spanish (76.3%) and 126 immigrants (23.7%). A decrease in the number of HIV diagnoses,
203 (38.2%) children in the first (P1), 149 (28%) in the second (P2), 130 (24.4%) in the third
(P3) and 50 (9.4%) in the fourth (P4) calendar periods was studied. The same decrease in
the Spanish HIV-infected children (P1, 174 (46.6%), P2, 115 (30.8%), P3, 65 (17.4%) and
P4, 19 (5.1%)) was monitored. However, an increase in the number of HIV diagnoses by
sexual contact (P1: 0%; P2: 1.3%; P3: 4.6%; P4: 16%) was observed. The rates of new peri-
natal HIV diagnoses and perinatal transmission in Spanish children decreased from 0.167
to 0.005 per 100,000 inhabitants and 11.4% to 0.4% between 1997 and 2015, respectively.
Conclusions
A decline of perinatal HIV diagnoses and transmission was observed. However, an increase
of teen-agers HIV diagnoses with sexual infection was studied. Public awareness cam-
paigns directed to teen-agers are advisable to prevent HIV infection by sexual contact.
Introduction
Perinatal HIV transmission has decreased to below 2% in newborns in high-income countries
(HIC) due to the prevention of mother-to-child transmission (PMTCT) and combination anti-
retroviral therapy (cART) [1–4]. However, information on sociodemographic changes and
trends in the rates of perinatal HIV transmission in Spain in the cART era has been obtained
from local cohorts [5–9], but not from a nationwide perspective. Although Spanish Informa-
tion Systems on New HIV Diagnoses (SINIVIH) include epidemiological, clinical and immu-
nological data on new HIV diagnoses since the year 2000, the implementation of the SINIVIH
was progressive, and did not cover all the Spanish population until the year 2013 [10].
Our objectives were: 1) to study sociodemographic changes in HIV-infected children and
teen-agers who were diagnosed in Spain; 2) to study sociodemographic changes in perinatally
HIV-infected children born in Spain and in their mothers; 3) to estimate the rate of new peri-
natal HIV diagnoses in children born in Spain; 4) to estimate the rate of perinatal HIV trans-
mission in Spain from 1997 to 2015.
Materials and methods
Data sources
The Spanish Pediatric HIV Network (CoRISpe). The Spanish Pediatric HIV Network
(CoRISpe), which collaborates actively with the Spanish HIV HGM BioBank, is an open, mul-
ticenter, retrospective, and prospective cohort founded in 2008 in accordance with Spanish
law on the protection of personal data [11–12]. CoRISpe collects epidemiological, clinical,
immunological, virological, analytical, and antiretroviral retrospective data from HIV-infected
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children and teen-agers since 1995 and the same prospective data from HIV-infected children
and teen-agers between the age of 0 and 18 years, with follow-up in Spanish pediatric HIV
units (SPHU) since 2008. At 31 December 2017, data from 1335 HIV-infected children and
teen-agers coming from 63 Spanish hospitals, belonging to 17 Autonomous Communities,
were collected in CoRISpe. Relevant results from those data on characteristics and trends of
new HIV diagnoses in Spain were obtained [13].
Spanish minimum basic data set. The Minimum Basic Data Set (MBDS) of the National
Surveillance System for Hospital Data in Spain, provided by the Ministry of Health, Consumer
Affairs and Social Welfare (MSSSI), is a clinical and administrative database containing clinical
information recorded at the time of hospital discharge. The MBDS has an estimated coverage
of 97.7% of total public hospital admissions. This database provides encrypted patient identifi-
cation numbers, gender, date of birth, postal codes of patient’s place, dates of hospital admis-
sion and discharge, medical institutions providing the services, the diagnosis and procedure
codes according to the International Classification of Diseases 9th Revision, Clinical Modifica-
tion (ICD-9-CM), as well as the outcome at discharge [14–15].
Ethics statement
The study was conducted according to the Declaration of Helsinki and was approved by the
Ethical Committees of each participating hospital of the CoRISpe working group, including
the Ethics and Clinical Research Committee of Paı´s Vasco, Arago´n, Navarra, La Rioja, Galicia,
Granada, Huelva, Hospital Universitario La Paz, Hospital Universitario Gregorio Maraño´n,
Hospital Universitario de Getafe, Hospital Universitario Doce de Octubre, Hospital Universi-
tario de Mostoles, Hospital Universitario Prı´ncipe de Asturias, Hospital de Torrejo´n, Hospital
Clinico San Carlos Complejo Hospitalario de Toledo, Complejo Hospitalario de Albacete Hos-
pital Marques de Valdecilla, Hospital Universitari Vall d’Hebron, Hospital Universitario Cen-
tral de Asturias, Hospital Universitario Nuestra Señora de la Candelaria, Complejo
Hospitalario Universitario Insular-Materno Infantil, Infanta Cristina de Badajoz, Complejo
Hospitalario de Ca´ceres, Hospital Universitario Virgen de la Arrixaca, Hospital Clı´nico Uni-
versitario de Valencia, Hospital Universitario La Fe, Hospital General de Castello´, Hospital
San Juan de Alicante, A´rea de Salud de Zamora, Hospital Clı´nico Universitario de Valladolid,
Complejo Asistencial de Leo´n, Hospital Regional Universitario Carlos Haya, Complejo Hospi-
talario de Torreca´rdenas, Hospital de Poniente, Hospital Universitario Virgen de las Nieves,
Hospital Universitario Virgen de la Macarena and Hospital Universitario Virgen del Rocı´o.
Written informed consent was obtained from all children’s parents/guardians, as well as from
all participants above 12 years old. Respect to the MDBS, the MSSSI evaluated the protocol of
our study and considered that it fulfilled all ethical considerations according to the Spanish
legislation. The data were treated with full confidentiality according to the Spanish legislation.
Children and data selection
HIV-infected children included in the CoRISpe who were diagnosed in Spain from 1st January
1997 to 31st December 2015 were included in the study. HIV-infected children were excluded
if they were diagnosed in foreign countries or if the children were first followed in SPHU not
participating in the CoRISpe.
1) Sociodemographic changes in HIV-infected children. At the time of HIV diagnosis
the collected data were sociodemographic (birth country, sex, HIV transmission and birth
date), clinical (Centers for Diseases Control and Prevention (CDC) stage: N-A: not or mildly
symptomatic; B: moderately symptomatic; C: severely symptomatic), comorbidity (HCV and
HBV infections), immunological (CD4+ T lymphocyte count (CD4/mm3) and CD4+ T-
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lymphocyte percent of total lymphocytes (%CD4)) and virological (viral load; (VL)) data in
copies/mL. Immunological categories based on %CD4 were used: category 1, no damage (25%
or over); category 2, moderate (15–24%); category 3, severe (less than 15%) [16]. According to
the year of HIV diagnosis four calendar periods were considered: period 1 (P1) from 1997 to
2000; period 2 (P2) from 2001 to 2005; period 3 (P3) from 2006 to 2010; period 4 (P4) from
2011 to 2015.
2) Sociodemographic changes in perinatally HIV-infected children born in Spain and
their mothers. Perinatally HIV-infected children born in Spain were selected. At HIV diag-
nosis, sociodemographic (sex, birth and diagnosis date), clinical (CDC stage, with the same
categories mentioned above: N-A: not or mildly symptomatic; B: moderately symptomatic; C:
severely symptomatic), comorbidity (HCV and HBV infections), immunological (CD4/mm3
and %CD4) and virological (VL) data of children were collected. The same immunological cat-
egories based on %CD4 mentioned above were used: category 1, no damage (25% or over); cat-
egory 2, moderate (15–24%); category 3, severe (less than 15%) [16]. According to the age of
HIV diagnosis, children were classified in three groups: 1) <1 year, if they were diagnosed
with<1 year of age; 2) 1–5 years, if they were diagnosed between 1 and 5 years of age; 3) >5
years, if they were diagnosed with>5 years of age. The following data were collected from
their mothers: birth country, mode of HIV transmission and period of HIV diagnosis. Accord-
ing to the period of HIV diagnosis, mothers were classified in two groups: 1) until childbirth, if
they were diagnosed before, during pregnancy or at childbirth; 2) after childbirth, if they were
diagnosed after childbirth.
According to the mode of HIV transmission, mothers were classified as: 1) intravenous
drug users (IDU), if they took intravenous drugs before or during pregnancy, and 2) No his-
tory of IDU, if they did not take them before or during pregnancy. The same four calendar
periods, mentioned above, were considered for the analysis, according to HIV diagnosis year
of the children (P1: 1997–2000; P2: 2001–2005; P3: 2006–2010; P4: 2011–2015).
3) Estimating the rate of new perinatal HIV diagnoses in children born in Spain. Peri-
natally HIV-infected children born in Spain were selected. Population projections in Spain
were obtained from the National Statistics Institute on the first day of December every year to
calculate rates, using the population of each year as the denominator [17]. Population of prov-
inces with no SPHU participating in the CoRISpe was excluded from the denominator. Popu-
lation of provinces with some SPHU participating in the CoRISpe, but not all, was adjusted
according to the proportion of HIV-infected children followed in those SPHU which partici-
pate in the CoRISpe. The total rate of new HIV diagnoses from 1997 to 2015 was calculated by
dividing the number of perinatally HIV-infected children by the sum of the corresponding
population in the study period (i.e., number of cases/100,000 inhabitants).
4) Estimating the rate of perinatal HIV transmission in Spain. All hospitalizations
between 1997 and 2015 that were coded in the MBDS with a childbirth procedure were
reviewed. The ICD-9-CM codes for defining childbirths were used: 72 (forceps, vacuum and
breech delivery); 73 (other procedures inducing or assisting delivery); 74 (cesarean section and
removal of fetus). Postal codes of patient’s place of residence to adjust the number of child-
births were used if these childbirths took place in the provinces with not SPHU participating
in the CoRISpe, or to adjust the number of childbirths, if these childbirths took place in the
provinces with some SPHU participating in the CoRISpe. ICD-9-CM codes 042 (HIV disease)
and V08 (asymptomatic HIV infection status) for defining HIV infection in the mothers were
used [15]. The percentage of childbirths from HIV-infected mothers that respect to total child-
births, per year, was calculated by dividing the number of childbirths from HIV infected moth-
ers by the total childbirths. Perinatally HIV-infected children born in Spain from 1st January
1997 to 31st December 2015, whose mothers were HIV-diagnosed until childbirth, were
Rates of new perinatal HIV diagnoses and infection in Spain from 1997 to 2015
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selected from the children included in our study to estimate the rate of perinatal HIV transmis-
sion. The rate of perinatal HIV transmission, per year, was estimated by dividing the number
of perinatally HIV-infected children by the number of childbirths from HIV-infected mothers.
Statistical analysis
Results involving categorical variables were expressed as proportions, whereas results involv-
ing continuous variables were expressed as medians and interquartile ranges.
Results
1) Sociodemographic changes in HIV-infected children
A total of 624 new cases of HIV-infected children and teen-ages in the CoRISpe were observed
from 1997 to 2015. Out of them, 77 children were excluded from this study because they were
not diagnosed with HIV infection in Spain. Fifteen children were excluded because they were
first followed in SPHU not participating in the CoRISpe. Of the remaining 532 children, 406
were Spanish (76.3%) and 126 were immigrants (23.7%) (Fig 1).
All children, except one HIV-2 infected child through blood products transfusion from
sub-Saharan Africa, were HIV-1 infected. Immigrant children came mainly from sub-Saharan
Africa (82 out of 126 (65.1%)) and Latin America (27 out of 126 (21.4%)). Children born in
foreign countries had lower %CD4 and CD4/mm3 and were in worse clinical situation at diag-
nosis than children born in Spain. A decrease in the number of HIV diagnoses was observed
through the calendar periods, mainly in Spanish children, whereas the number of immigrant
children increased from P1 to P3 and decreased in P4 (Table 1).
Thirteen children were HCV-coinfected, all were Spanish except one child from sub-Saha-
ran Africa. Nine children were HBV-coinfected, all were from sub-Saharan Africa except one
child from Eastern Europe (Table 1). Sixteen teen-agers, 8 male and 8 female, were HIV-
infected by sexual contact. They were mainly from Latin America (8 out of 16 (50%)) and
Spain (6 out of 16 (37.5%)), with median age 16.4 years [IQR: 15.4–16.7], 26%CD4 [IQR:
Fig 1. Flow-chart for the selection of HIV-infected children diagnosed in Spain from 1997 to 2015.
https://doi.org/10.1371/journal.pone.0223536.g001
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20.5–31] and 510 CD4/mm3 [IQR: 394–631] at diagnosis. Twelve out of 16 teen-agers (75%)
had CDC stage A, 2 out 16 (12.5%) had CDC stage B and 2 out of 16 (12.5%) had CDC stage C
at diagnosis. Three out of 16 (18.8%) had<350 CD4/mm3, two of them had <200 CD4/mm3.
A slight increase in sexual HIV diagnoses was observed throughout the study period (P1: 0
out of 203 (0%); P2: 2 out of 149 (1.3%); P3: 6 out of 130 (4.6%); P4: 8 out of 50 (16%)). See S1
Table for complete data by origin of the children.
2) Sociodemographic changes in perinatally HIV-infected children born in
Spain and their mothers
Out of 406 Spanish children, 387 (95.3%) were perinatally HIV-infected. Origin of 373 moth-
ers could be obtained, 299 were Spanish (80.2%) and 74 immigrants (19.8%) (Fig 1). Immi-
grant mothers were mainly from sub-Saharan Africa (39 out of 74 (52.7%)) and Latin America
(19 out of 74 (25.7%)). A decrease in the number of HIV-diagnosed children throughout the
study period was observed. This decrease was observed mainly in children born from Spanish
mothers, whereas the number of HIV-diagnosed children born from immigrant mothers
increased from P1 to P3, but declined in P4. There was a higher percentage of Spanish IDU
Table 1. Sociodemographic, clinical, immunological and virological profile of the HIV-infected children at diag-
nosis, by origin of the children.
Spanish Immigrants
N = 406 N = 126
Calendar period, N (%)
1997–2000 191 (47) 12 (9.5)
2001–2005 118 (29.1) 31 (24.6)
2006–2010 73 (18) 57 (45.2)
2011–2015 24 (5.9) 26 (20.6)
Sex, N (%)
Male 187 (46.1) 64 (50.8)
Female 219 (53.9) 62 (49.2)
HIV transmission mode, N (%)
Perinatal 387 (95.3) 89 (70.6)
Transfusional 3 (0.7) 11 (8.7)
Sexual 6 (1.5) 10 (7.9)
Unknown (mother not HIV infected) 10 (2.5) 2 (1.6)
Unknown (HIV mother status not known) 0 (0) 14 (11.1)
CDC stage, N (%) N = 402 N = 125
N-A 267 (66.4) 61 (48.8)
B 78 (19.4) 31 (24.8)
C 57 (14.2) 33 (26.4)
Coinfections, N (%)
HCV 12 (3) 1 (0.8)
HBV 0 (0) 9 (7.1)
%CD4, Median (IQR) N = 346 N = 119
28 (15.2–40) 17 (8.3–24.7)
CD4/mm3, Median (IQR) N = 348 N = 119
1176 (465–2185) 547 (213–1036)
Log Viral Load, Median (IQR) N = 354 N = 118
5.2 (4.6–5.9) 5.1 (4.5–5.7)
https://doi.org/10.1371/journal.pone.0223536.t001
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mothers than immigrant IDU mothers (52% vs. 5.6%, respectively). A decrease in the number
of IDU mothers was observed through the calendar periods (Table 2).
Eleven children were HCV-coinfected, all born from Spanish IDU mothers except one
child born from a Latin America mother, who was HIV-infected by sexual contact. A decrease
in the number of HCV-coinfected children was observed through the calendar periods, with
no cases in P3 and P4. Regarding the clinical and immune situation, a decrease in the number
of children with CDC B and C stages was observed throughout the study period, as well as a
slight increase in %CD4 (Table 2). See S2 Table for complete data by origin of the mothers.
3) Estimating the rate of new perinatal HIV diagnoses in children born in
Spain
Out of 406 Spanish children, 387 perinatally HIV-infected children were selected (Fig 1). A
decrease in the rate of new diagnoses by perinatal transmission per 100,000 inhabitants was
observed, from 0.167 in 1997 to 0.005 in 2015 (Fig 2).
Table 2. Sociodemographic, clinical, immunological and virological profile at diagnosis of perinatally HIV-infected children born in Spain and their mothers, by
calendar periods.
1997–2000 2001–2005 2006–2010 2011–2015
N = 174 N = 115 N = 65 N = 19
Origin of mothers, N (%)
Spanish 163 (93.7) 95 (82.6) 32 (49.2) 9 (47.4)
Immigrants 11 (6.3) 20 (17.4) 33 (50.8) 10 (52.6)
Period of HIV diagnosis for mothers, N (%)
Until childbirth 89 (51.1) 47 (40.9) 36 (55.4) 10 (52.6)
After childbirth 85 (48.9) 68 (59.1) 29 (44.6) 9 (47.4)
Mode of HIV transmission of mothers, N (%) N = 163 N = 110 N = 61 N = 18
IDU 90 (55.2) 47 (42.7) 11 (18) 2 (11.1)
No history of IDU 73 (44.8) 63 (57.3) 50 (82) 16 (88.9)
Sex of children, N (%)
Male 71 (40.8) 60 (52.2) 29 (44.6) 8 (42.1)
Female 103 (59.2) 55 (47.8) 36 (55.4) 11 (57.9)
Age of children, N (%)
<1 year 109 (62.6) 74 (64.3) 45 (69.2) 13 (68.4)
1–5 years 51 (29.3) 25 (21.7) 15 (23.1) 4 (21.1)
>5 years 14 (8) 16 (13.9) 5 (7.7) 2 (10.5)
Coinfections in children, N (%)
HCV 9 (5.2) 2 (1.7) 0 (0) 0 (0)
HBV 0 (0) 0 (0) 0 (0) 0 (0)
CDC stage of children, N (%) N = 169 N = 113 N = 65 N = 19
N-A 87 (51.4) 71 (62.8) 47 (72.3) 17 (89.5)
B 41 (24.3) 26 (23) 9 (13.8) 1 (5.3)
C 41 (24.3) 16 (14.2) 9 (13.8) 1 (5.3)
%CD4, Median (IQR) N = 148 N = 99 N = 63 N = 19
27.4 (16–36) 27 (13.9–40.5) 31.7 (21–46) 36 (27.5–44.9)
CD4/mm3, Median (IQR) N = 149 N = 99 N = 63 N = 19
1192 (439–2126) 1145 (578–2126) 1775 (691–2963) 1489 (935–2567)
Log Viral Load, Median (IQR) N = 153 N = 99 N = 63 N = 18
5.5 (4.9–6.1) 5.2 (4.7–5.7) 5.2 (4.2–5.9) 5.1 (4.5–5.7)
https://doi.org/10.1371/journal.pone.0223536.t002
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4) Estimating the rate of perinatal HIV transmission in Spain
From 6,441,654 childbirths reviewed in MDBS, 1,364,879 (21.2%) were excluded after being
adjusted by postal codes of patient’s place of residence. Of the remaining 5,076,775 childbirths,
6328 were from HIV-infected mothers (1.25‰). The proportion of childbirths from HIV-
infected mothers respect to total childbirths increased from 0.96‰ in 1997 to 1.7‰ in 2000
and then decreased to 0.96‰ in 2015 (Fig 3).
From 387 perinatally HIV-infected children born in Spain, 308 (79.6%) were born from 1st
January 1997 to 31st December 2015. Of them, 25 (8.1%) were excluded to adjust the number
of childbirths by postal codes of patient’s place of residence. Of the remaining 283 children, in
158 (55.8%) their mothers were diagnosed until childbirth (Fig 1). The estimated rate of peri-
natal HIV transmission in Spain decreased from 11.4% in 1997 to 0.4% in 2015 (Fig 4).
Discussion
This is the first nationwide study showing the changes in characteristics of HIV-infected chil-
dren and the trends of perinatal HIV transmission in Spain in the era of cART [6–9]. In our
study 532 children, who were HIV-diagnosed in Spain between 1997 and 2015, were included.
We observed a decrease in the number of HIV diagnoses throughout the study period, mainly
in Spanish HIV-infected children, and an increase in the number of HIV diagnoses in teen-
agers with sexual infection. We also observed a decrease in the rates of new perinatal HIV diag-
noses and perinatal transmission in children born in Spain.
Of the 532 children included, 406 were Spanish (76.3%) and 126 were immigrants (23.7%).
Immigrant children came mainly from sub-Saharan Africa, as other studies made in Western
Europe [4, 18–19], and Latin America. These children probably immigrated to Spain with
their families for linguistic and cultural reasons [20]. The immigrant children had worse clini-
cal and immunological situation at HIV diagnosis than Spanish children. It is essential to
screen immigrant children, who emigrate from countries with high HIV prevalence, to achieve
an earlier diagnosis and start as soon as possible cART [3].
We observed a decline in the number of new diagnoses from 1997 to 2015, mainly in Span-
ish children. However, the number of immigrant children increased from 1997 to 2010 and
decreased until 2015. Spain was a major migrant destination during the first decade of this
century, but immigration declined afterwards, probably due to the Spanish financial crisis.
Therefore, the number of HIV diagnoses in immigrant children grew from 1997 to 2010 and
declined until 2015 [21].
The increase in the number of HIV diagnoses in teen-agers by sexual contact is also
remarkable. Teen-agers and young adults represent an increasing group of HIV-infected peo-
ple worldwide. Approximately, 590,000 young adults from 15 to 24 years-old were HIV-
infected worldwide in 2017. A recent study shows that young adults in Spain do not have
appropriate knowledge of modes of HIV transmission [22]. Some possible reasons may
include loss of fear of AIDS, motivated by the efficacy of cART, recreational drug associated
with sexual intercourse or use of mobile applications to search risky sexual contacts [23, 24].
Public awareness campaigns directed to teen-agers are advisable to prevent HIV infection by
sexual contact [25, 26].
Out of 387 Spanish perinatally HIV-infected children, the origin of 373 mothers was
known, 299 were Spanish (80.2%) and 74 were immigrants (19.8%). Immigrant mothers came
mainly from sub-Saharan Africa and Latin America. We observed a decrease in the number of
perinatal HIV diagnoses throughout the study period, mainly in children born from Spanish
mothers. However, the number of children born from immigrant mothers increased from
1997 to 2010 and decreased until 2015. This trend was similar to the one observed in HIV-
Rates of new perinatal HIV diagnoses and infection in Spain from 1997 to 2015
PLOS ONE | https://doi.org/10.1371/journal.pone.0223536 October 24, 2019 8 / 16
infected immigrant children and was probably due to the Spanish financial crisis [21]. We also
saw a decrease in the percentage of children with CDC B and C stage and an increase in %CD4
at diagnosis through the calendar periods. These findings were probably due to the administra-
tion of HIV testing to all pregnant women, according to the recommendations of the Spanish
Health Ministry and Clinical Guidelines. Subsequently, new perinatal HIV infections were
prevented, fewer HIV-infected mothers were diagnosed after childbirth and fewer HIV-
infected children were diagnosed with bad clinical and immune situation [1–4, 27–28]. Inter-
estingly, we saw a decrease in the number of IDU mothers and HCV-coinfected children.
Spain was one of the European countries more affected by the heroin epidemic in the 80’s.
Therefore, most of HIV and HCV co-infections during the first years of the HIV epidemic
took place through intravenous drugs [29]. However, the number of IDU decreased from 1994
(5102 out of 7495 new AIDS cases (68.1%)), to 2015 (84 out of 597 new AIDS cases (14.1%))
[10].
Fig 2. Rate of new perinatal HIV diagnoses in children born in Spain from 1997 to 2015.
https://doi.org/10.1371/journal.pone.0223536.g002
Fig 3. Proportion of childbirths from HIV-infected mothers in respect to total childbirths.
https://doi.org/10.1371/journal.pone.0223536.g003
Rates of new perinatal HIV diagnoses and infection in Spain from 1997 to 2015
PLOS ONE | https://doi.org/10.1371/journal.pone.0223536 October 24, 2019 9 / 16
We saw a decline in the rates of perinatal HIV diagnoses and perinatal transmission in
Spanish children throughout the study period, due to PMTCT measures. However, this decline
could be also influenced by the decrease observed in the number of HIV-infected mothers
from 2000 to 2015. The number of new perinatal HIV diagnoses in Europe decreased by 47%
from 2008 (673) to 2017 (360), representing 1.4% of all new HIV diagnoses in 2008 and 0.8%
in 2017 [18]. In this sense, current rates in perinatal HIV transmission in Spain are similar to
the ones observed in other European and American countries [30–35].
Furthermore, our results suggest that Spain meets the three World and Health Organization
(WHO) impact targets for elimination of perinatal HIV transmission [36]. Our study shows
that: 1) the number of diagnoses of Spanish perinatally HIV-infected children decreased
through the calendar periods, from P1 (174) to P4 (19), whereas total childbirths ranged
between 293,518 in 2011 to 262,828 in 2015; 2) the rate of perinatal HIV transmission was
below 2% from 2010 (1.4%) to 2015 (0.4%). Regarding the third impact target, there is no
Spanish registry of HIV-infected pregnant women. In consequence, it is not possible to know
the real number of pregnant women living with HIV in Spain. However, coverage of HIV
screening for pregnant women is universal in Spain. The Spanish Clinical Guides recommend
HIV screening for all pregnant women within the first 3 months of pregnancy and in the third
trimester if the previous test was negative. Furthermore, PMTCT measures are offered to all
HIV-diagnosed pregnant women, and nucleic acid tests to detect HIV RNA or DNA are avail-
able for infant testing at birth, at 4–6 weeks and at 4–6 months. Thus, Spain would meet the
three impact targets and the validation criteria for elimination of perinatal HIV transmission.
Our study has important limitations: first, SPHU from some provinces could not partici-
pate in our study. Second, the study used retrospective data, and some data of children
included in our study were not available. However, the CoRISpe collects data from approxi-
mately 85% of all HIV-infected children diagnosed in Spain. Furthermore, the rates of perina-
tal HIV diagnoses and perinatal transmission were adjusted to consider HIV-infected children
followed in SPHU not participating in the CoRISpe. Therefore, we believe that the data of
SPHU children who do not participate in the CoRISpe and the missing data of the children
included in the study, likely did not affect our results. Third, MDBS does not collect data about
the clinical and immunological situation of HIV-infected mothers, origin, time of HIV diagno-
sis and cART received during their pregnancy and at childbirth. Therefore, it is not possible to
Fig 4. Rate of perinatal HIV transmission from 1997 to 2015.
https://doi.org/10.1371/journal.pone.0223536.g004
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know if there are any differences in regard to risk factors for perinatal HIV transmission
between Spanish and immigrant mothers. Fourth, MDBS only collects data from public hospi-
tals, and it is possible that some HIV-infected mothers gave birth in private hospitals or even
at home. In consequence, the proportion of childbirths from HIV-infected mothers in respect
to total childbirths and the rate of perinatal transmission could be different. Fifth, postal codes
of patient’s place of residence were used to adjust the number of childbirths, and it is possible
that some mothers gave birth in hospitals belonging to other provinces. Sixth, there are neither
registries nor studies regarding voluntary abortions in HIV-infected women in Spain. Data
from MDBS used in our study included only hospitalizations that were coded with a childbirth
procedure. An epidemiological surveillance system of HIV-infected pregnant women in Spain
could be set up, to clarify these questions.
In conclusion, we think that additional measures are needed to minimize the risk of perina-
tal HIV transmission in Spain. Universal antenatal screening is important to identify HIV-
infected women. Therefore, HIV testing should be offered to all women of childbearing age
and women who seek preconception counselling. In addition, routine HIV testing should be
also offered to teen-agers and young adult patients in primary health care clinics [37].
Although immigrant pregnant women have universal healthcare in Spain, we think that preg-
nancy awareness campaigns should be organised among immigrants. Finally, an epidemiologi-
cal surveillance system of HIV-infected pregnant women in Spain could be set up, to make
further studies about trends and risk factors in perinatal HIV transmission.
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